Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05807984
PHASE2

Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion

Sponsor: Xin Cai

View on ClinicalTrials.gov

Summary

Prospective phase II clinical study aim to explore the clinical outcome of patients with unresectable locally recurrent rectal cancer (LRRC) treated with re-irradiation by carbon ion radiotherapy (CIRT)

Official title: A Prospective Phase II Clinical Study of Carbon Ion Re-irradiation in Unresectable Locally Recurrent Rectal Cancer

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

31

Start Date

2023-05-01

Completion Date

2026-12-31

Last Updated

2023-04-11

Healthy Volunteers

No

Interventions

RADIATION

Carbon ion radiation therapy DT: 74Gy/20 fractions

patients with unresectable local recurrent rectal cancer will be treated with carbon ion radiation therapy as re-irradiation

Locations (1)

Shanghai Proton and Heavy ion center

Shanghai, Pudong, China